(MACHEREY-NAGEL, Düren, Germany). PCR reactions (35 to 37 cycles) using primers for the β-actin and RatPyV2 virus protein 1 (VP1) were performed as described previously [15 (link)]. Sequencing of a larger region of VP1 (primer pair F14-R7, 432-bp [15 (link)]) was performed by Macrogen Japan Corp.
(Kyoto, Japan).
For buccal swabs, direct PCR amplification by the Amp-FTA method was conducted [12 ]. Briefly, buccal swabs were collected with 4N6 FLOQSwabs (Copan,
Brescia, Italy) and immediately smeared on the Whatman Indicating FTA Card (GE Healthcare, Little Chalfont, U.K.). Discs (1.5 mm diameter) were punched out from the FTA card by a standard
ear punch and were directly used as templates (one disc for each reaction). PCR reactions (40 cycles) using primers for β-actin and RatPyV2 VP1 [15 (link)]
were performed in Ampdirect Plus buffer (Shimadzu Corp., Kyoto, Japan). As a negative control, we used immunocompetent F344/NSlc strains that were negative for RatPyV2 serological assay, as
conducted by IDEXX BioResearch (Columbia, MO, U.S.A.).